Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy: Randomized, Placebo-Controlled Study (FIRST).
CONCLUSIONS: Compared with atorvastatin monotherapy, FA plus atorvastatin did not further decrease cIMT progression in high-risk patients with mixed dyslipidemia.
PMID: 24743431 [PubMed - as supplied by publisher]
Source: Arteriosclerosis, Thrombosis and Vascular Biology - Category: Cardiology Authors: Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC Tags: Arterioscler Thromb Vasc Biol Source Type: research
More News: Arteriosclerosis | Atorvastatin Calcium | Biology | Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Fenofibrate | Heart | Heart Disease | Lipitor | Statin Therapy | Study | Thrombosis | Tricor | Trilipix | Ultrasound | Women | Zivast